Correlation of UGT1A1 Gene Polymorphisms or Prior Irinotecan Treatment and Treatment Outcomes of Nanoliposomal-Irinotecan plus 5-Fluorouracil/Leucovorin for Pancreatic Ductal Adenocarcinoma: A Multicenter, Retrospective Cohort Study (HGCSG2101)

The effects of UGT1A1 gene polymorphisms or prior irinotecan treatment on treatment outcomes of nanoliposomal-irinotecan plus 5-fluorouracil/leucovorin (nal-IRI+5-FU/LV) in patients with unresectable pancreatic ductal adenocarcinoma (PDAC) are not established. This multicenter, retrospective cohort...

Descripción completa

Detalles Bibliográficos
Autores principales: Harada, Kazuaki, Yamamura, Takahiro, Muto, Osamu, Nakamura, Michio, Sogabe, Susumu, Sawada, Kentaro, Nakano, Shintaro, Yagisawa, Masataka, Muranaka, Tetsuhito, Dazai, Masayoshi, Tateyama, Miki, Kobayashi, Yoshimitsu, Kato, Sosuke, Hatanaka, Kazuteru, Kawamoto, Yasuyuki, Yuki, Satoshi, Sakata, Yuh, Sakamoto, Naoya, Komatsu, Yoshito
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9963652/
https://www.ncbi.nlm.nih.gov/pubmed/36836140
http://dx.doi.org/10.3390/jcm12041596

Ejemplares similares

Ejemplares similares